BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 10, 2005
View Archived Issues
FR-255031 prevents progression of joint destruction in arthritic rats
Read More
Nonimmunosuppressive immunophilin FK-1706 potentiates neurite outgrowth in vitro
Read More
Novel therapeutic strategy for heart failure effective in dogs
Read More
New data on the pharmacokinetics of roflumilast in pediatric patients
Read More
Clinical evidence supports the use of TroVax in metastatic colorectal cancer
Read More
Clinical evaluation of prasugrel as inhibitor of platelet aggregation
Read More
Flamel Technologies terminates Genvir license agreement with Biovail
Read More
SPA agreement for pivotal study of INO-1001
Read More
New phase I/II study evaluates Amplimexon plus gemcitabine
Read More
HEALOS(R)-MP52 advantageous in treating long bone defects
Read More
Istradefylline maintains efficacy in Parkinson's disease over one year
Read More
Coenzyme Q10 use remains limited in Parkinson's disease outpatients
Read More
In vivo efficacy of combined warfarin/probucol therapy for steroid-induced osteonecrosis
Read More
Chinese clinical program progresses for Calypte's HIV-1/2 tests
Read More
Senexis and BioFocus to develop novel small-molecule drugs for Alzheimer's
Read More
Pivotal trial brought forward for phenoxodiol for chemoresistant ovarian cancer
Read More
Remodulin receives the first European approval in France
Read More
Enrollment reaches half way in phase III HIV prevention study of Savvy
Read More
Promising findings for VNS Therapy in bulimia nervosa
Read More
New Melanotan trials cleared to begin in Australia and Finland
Read More
Tsumura discontinues development of TJN-598
Read More
Org-24461 reverses negative symptoms of schizophrenia in preclinical models / News in Context
Read More
Seletracetam reduces levodopa-induced dyskinesia in marmosets
Read More
Induction of HSP70 produces neuroprotective effects
Read More
Indoleamine 2,3-dioxygenase inhibitors improve chemotherapy / News in Context
Read More
Novel cathepsin S inhibitors disclosed by IRM
Read More
HIV reverse transcriptase inhibitors discovered at the University of Illinois
Read More
Galderma discloses new PPARgamma receptor agonists
Read More
HER (erbB) family kinase inhibitors for the treatment of cancer reported by GSK
Read More
Merck claims new KSP inhibitors and their use in treating cancer
Read More
